Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Cystic Fibrosis (CF) Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.7% during the forecast period.
This report presents the market size and development trends by detailing the Cystic Fibrosis (CF) Therapeutics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cystic Fibrosis (CF) Therapeutics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cystic Fibrosis (CF) Therapeutics industry and will help you to build a panoramic view of the industrial development.
Cystic Fibrosis (CF) Therapeutics Market, By Type:
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Cystic Fibrosis (CF) Therapeutics Market, By Application:
Oral drugs
Inhaled drugs
Some of the leading players are as follows:
F. Hoffmann-La Roche Ltd
AIT (Advanced Inhalation Therapies)
Alcresta
AstraZeneca
AbbVie,
F Hoffmann-La Roche Ltd
Novartis AG
Alaxia
Merck & Co.
Gilead
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticalsorporated
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Cystic Fibrosis (CF) Therapeutics Market: Technology Type Analysis
-
4.1 Cystic Fibrosis (CF) Therapeutics Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Cystic Fibrosis (CF) Therapeutics Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Pancreatic enzyme supplements
4.3.2 Mucolytics
4.3.3 Bronchodilators
4.3.4 CFTR modulators
5 Cystic Fibrosis (CF) Therapeutics Market: Product Analysis
-
5.1 Cystic Fibrosis (CF) Therapeutics Product Market Share Analysis, 2018 & 2026
-
5.2 Cystic Fibrosis (CF) Therapeutics Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Cystic Fibrosis (CF) Therapeutics Market: Application Analysis
-
6.1 Cystic Fibrosis (CF) Therapeutics Application Market Share Analysis, 2018 & 2026
-
6.2 Cystic Fibrosis (CF) Therapeutics Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Oral drugs
6.3.2 Inhaled drugs
7 Cystic Fibrosis (CF) Therapeutics Market: Regional Analysis
-
7.1 Cystic Fibrosis (CF) Therapeutics Regional Market Share Analysis, 2018 & 2026
-
7.2 Cystic Fibrosis (CF) Therapeutics Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 F. Hoffmann-La Roche Ltd
9.1.1 F. Hoffmann-La Roche Ltd Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 AIT (Advanced Inhalation Therapies)
9.2.1 AIT (Advanced Inhalation Therapies) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Alcresta
9.3.1 Alcresta Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 AstraZeneca
9.4.1 AstraZeneca Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 AbbVie,
9.5.1 AbbVie, Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 F Hoffmann-La Roche Ltd
9.6.1 F Hoffmann-La Roche Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Novartis AG
9.7.1 Novartis AG Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Alaxia
9.8.1 Alaxia Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Merck & Co.
9.9.1 Merck & Co. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Gilead
9.10.1 Gilead Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Teva Pharmaceutical Industries Ltd
9.11.1 Teva Pharmaceutical Industries Ltd Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Vertex Pharmaceuticalsorporated
9.12.1 Vertex Pharmaceuticalsorporated Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 63 Figures and 131 Tables)
Figure Pancreatic enzyme supplements Cystic Fibrosis (CF) Therapeutics market, 2015 - 2026 (USD Million)
Figure Mucolytics Cystic Fibrosis (CF) Therapeutics market, 2015 - 2026 (USD Million)
Figure Bronchodilators Cystic Fibrosis (CF) Therapeutics market, 2015 - 2026 (USD Million)
Figure CFTR modulators Cystic Fibrosis (CF) Therapeutics market, 2015 - 2026 (USD Million)
Figure Oral drugs market, 2015 - 2026 (USD Million)
Figure Inhaled drugs market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Cystic Fibrosis (CF) Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table North America Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table North America Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table North America Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Canada Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Canada Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Europe Cystic Fibrosis (CF) Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table Europe Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Europe Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Europe Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Germany Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Germany Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table France Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table France Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Italy Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Italy Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Spain Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Spain Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Cystic Fibrosis (CF) Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table China Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table China Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Japan Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Japan Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table India Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table India Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Cystic Fibrosis (CF) Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table MEA Cystic Fibrosis (CF) Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table MEA Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table MEA Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table MEA Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Cystic Fibrosis (CF) Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Cystic Fibrosis (CF) Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Cystic Fibrosis (CF) Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AIT (Advanced Inhalation Therapies) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alcresta Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AbbVie, Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alaxia Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gilead Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Industries Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Vertex Pharmaceuticalsorporated Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
